Solara Active Pharma Sciences declares Q1 FY27 Unaudited Financial Results

Solara Active Pharma Sciences Limited has announced the submission of its unaudited financial results for the quarter ended June 30, 2026. The results, which were approved by the Board of Directors at a meeting held on July 23, 2026, cover both standalone and consolidated financial statements. A limited review report from M/s. Deloitte Haskins & Sells, Chartered Accountants, has also been submitted. The financial results will be made available on the company's investor relations website.